Statements (58)
| Predicate | Object |
|---|---|
| gptkbp:instance_of |
gptkb:healthcare_organization
|
| gptkbp:bfsLayer |
4
|
| gptkbp:bfsParent |
gptkb:Enbrel
gptkb:Taltz gptkb:Skyrizi gptkb:rituximab |
| gptkbp:affects |
joints
|
| gptkbp:associated_with |
psoriasis
|
| gptkbp:can_be |
progressive
chronic |
| gptkbp:can_lead_to |
gptkb:hospital
metabolic syndrome joint damage comorbidities |
| gptkbp:caused_by |
fatigue
nail changes eye inflammation |
| https://www.w3.org/2000/01/rdf-schema#label |
psoriatic arthritis
|
| gptkbp:is_aimed_at |
stress
injuries infections |
| gptkbp:is_associated_with |
gptkb:historical_event
anxiety fatigue |
| gptkbp:is_characterized_by |
inflammation
skin lesions dactylitis |
| gptkbp:is_considered_as |
a chronic inflammatory disease
|
| gptkbp:is_linked_to |
environmental factors
genetic factors immune system dysfunction |
| gptkbp:is_often_used_in |
gptkb:philosopher
gptkb:Person adults men |
| gptkbp:is_popular_in |
1-3% of the population
|
| gptkbp:is_related_to |
gptkb:healthcare_organization
autoimmune diseases |
| gptkbp:is_studied_in |
clinical trials
|
| gptkbp:managed_by |
gptkb:stadium
multidisciplinary teams physical therapy lifestyle changes |
| gptkbp:risk_factor |
obesity
family history smoking |
| gptkbp:social_responsibility |
clinical evaluation
imaging tests rheumatologists |
| gptkbp:symptoms |
stiffness
swelling joint pain |
| gptkbp:treatment |
corticosteroids
nonsteroidal anti-inflammatory drugs phototherapy biologic drugs DMAR Ds targeted synthetic DMAR Ds |